Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Source of iron overload in multiple sclerosis.
Depressive Symptoms in Multiple Sclerosis from an In Vivo Study with TBSS.
Place of perineal electrophysiologic testing in multiple sclerosis patients.
Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Acute inflammatory myelopathies.
An MRI review of acquired corpus callosum lesions.
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases.
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
Double Inversion Recovery Sequence of the Cervical Spinal Cord in Multiple Sclerosis and Related Inflammatory Diseases.
[Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Neuro-ophthalmology update.
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
[Natalizumap can induce progressive multifocal leucoencephalopathy.]
Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Correlations between serum uric Acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.
Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Multiple sclerosis. Recent modalities of treatment.

Pages